Governance record · 2026
Responsible growth needs a public control record.
NEUVIOR Pharmaceuticals Ltd has adopted a voluntary Modern Slavery Assessment and Statement. The signed PDF is preserved below as the authoritative public record.
01 · Public position
A proportionate statement for the company's current scale.
NEUVIOR Pharmaceuticals Ltd has published the statement voluntarily. The company has stated that it is currently below the turnover threshold at which section 54 of the Modern Slavery Act 2015 typically requires annual reporting.
The record describes an approach based on risk to responsible supplier management and worker protection. It should be read in the context of NEUVIOR's present scale and current operating activities.
This webpage is a navigation and accessibility layer. If its summary differs from the signed document, the signed PDF is the controlling record.
Supplier assessment
The signed statement records the company's approach to proportionate supplier screening and due diligence.
See signed PDFTraining and escalation
The record sets out expectations for awareness, escalation and proportionate remediation.
See signed PDFReview and improvement
Controls are intended to be reviewed as NEUVIOR's activities, scale and supply relationships develop.
Proportionate to scale02 · Document control
The signature and version belong to the document itself.
The file retained on this page is the electronically signed 2026 statement. Its title, version, signature and approval record should be assessed from the PDF rather than inferred from decorative website content.
The website does not convert the voluntary statement into a wider certification, regulatory approval or assurance claim.
Questions about the statement or its application can be sent directly to [email protected].
Signed source document
Read the record in its original form.
If your browser cannot display the document, use the download link above. The PDF is the authoritative record.
Make the next step useful
Bring the problem that needs a clearer decision.
Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.